Explore more publications!

Trump Signs Order Designating Fentanyl as "Weapon of Mass Destruction"

(MENAFN) President Donald Trump issued an executive order Monday officially classifying fentanyl as a "weapon of mass destruction," marking a dramatic escalation in the administration's response to the opioid crisis.

The declaration came during an Oval Office ceremony where Trump honored military service members deployed for border enforcement missions. The president framed the synthetic opioid epidemic as an existential national security threat surpassing conventional warfare.

"No bomb does what this is doing," Trump said, adding that "200,000 to 300,000 people die each year."

The commander-in-chief also touted his administration's border policies, claiming unprecedented success in stemming illegal crossings.

"We took the worst border in the history of our country, and in a period of two months, we turned it into the strongest border in the history of our country," he added.

The WMD designation could unlock additional military resources and authorities to combat fentanyl trafficking networks, though the full legal implications remain unclear. The move signals a hardline approach connecting drug enforcement with national defense priorities.

MENAFN16122025000045017169ID1110485556


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions